Edgar G. Engleman

33.3k total citations · 11 hit papers
277 papers, 24.9k citations indexed

About

Edgar G. Engleman is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Edgar G. Engleman has authored 277 papers receiving a total of 24.9k indexed citations (citations by other indexed papers that have themselves been cited), including 208 papers in Immunology, 54 papers in Molecular Biology and 48 papers in Oncology. Recurrent topics in Edgar G. Engleman's work include Immunotherapy and Immune Responses (114 papers), T-cell and B-cell Immunology (110 papers) and Immune Cell Function and Interaction (97 papers). Edgar G. Engleman is often cited by papers focused on Immunotherapy and Immune Responses (114 papers), T-cell and B-cell Immunology (110 papers) and Immune Cell Function and Interaction (97 papers). Edgar G. Engleman collaborates with scholars based in United States, Canada and Germany. Edgar G. Engleman's co-authors include Claudia Benike, Lawrence Fong, Robert Yuan, Sreya Bagchi, Ronald Levy, Barry S. Stein, Miriam Mérad, Jeffrey D. Lifson, Daniel A. Winer and Debra K. Czerwinski and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Edgar G. Engleman

274 papers receiving 24.1k citations

Hit Papers

Vaccination of patients w... 1986 2026 1999 2012 1996 2020 2009 2011 2002 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
    1996 1.5k citations Claudia Benike, Edgar G. Engleman et al. profile →
  2. Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
    2020 1.5k citations Edgar G. Engleman et al. profile →
  3. Normalization of obesity-associated insulin resistance through immunotherapy
    2009 1.1k citations Edgar G. Engleman, Daniel A. Winer et al. profile →
  4. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies
    2011 806 citations Daniel A. Winer, Lei Shen et al. profile →
  5. Langerhans cells renew in the skin throughout life under steady-state conditions
    2002 732 citations Edgar G. Engleman et al. profile →
  6. Systemic Immunity Is Required for Effective Cancer Immunotherapy
    2017 687 citations Nathan E. Reticker-Flynn, Tyler R. Prestwood et al. profile →
  7. Dendritic Cells in Cancer Immunotherapy
    2000 563 citations Lawrence Fong, Edgar G. Engleman profile →
  8. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane
    1987 525 citations Edgar G. Engleman et al. profile →
  9. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein
    1986 521 citations Edgar G. Engleman et al. profile →
  10. Role of innate and adaptive immunity in obesity-associated metabolic disease
    2017 346 citations Lei Shen, Edgar G. Engleman et al. profile →
  11. Neutrophil-activating therapy for the treatment of cancer
    2023 117 citations Tyler R. Prestwood, Xiangyue Zhang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edgar G. Engleman United States 78 15.5k 6.0k 5.8k 3.7k 2.1k 277 24.9k
Herbert C. Morse United States 81 12.1k 0.8× 8.0k 1.3× 3.6k 0.6× 2.8k 0.8× 1.6k 0.8× 437 22.8k
Craig Gérard United States 86 16.2k 1.0× 6.3k 1.1× 5.8k 1.0× 3.5k 1.0× 1.5k 0.7× 223 29.5k
Vincenzo Cerundolo United Kingdom 91 21.6k 1.4× 6.9k 1.2× 5.6k 1.0× 3.8k 1.0× 1.2k 0.6× 307 28.0k
René A. W. van Lier Netherlands 85 16.4k 1.1× 3.3k 0.6× 4.2k 0.7× 4.4k 1.2× 1.7k 0.8× 350 22.7k
Thomas J. Schall United States 75 15.7k 1.0× 4.3k 0.7× 10.3k 1.8× 2.9k 0.8× 1.2k 0.6× 185 25.8k
Dennis A. Carson United States 88 11.1k 0.7× 11.4k 1.9× 5.7k 1.0× 3.0k 0.8× 4.2k 2.0× 467 29.3k
Ian Clark‐Lewis Canada 82 14.7k 0.9× 9.9k 1.7× 12.0k 2.1× 2.2k 0.6× 2.1k 1.0× 202 29.6k
Barrett J. Rollins United States 71 10.8k 0.7× 6.0k 1.0× 8.0k 1.4× 2.3k 0.6× 785 0.4× 126 23.0k
Hans Wigzell Sweden 80 17.8k 1.1× 6.2k 1.0× 3.6k 0.6× 3.2k 0.9× 5.0k 2.3× 489 28.6k
Howard A. Young United States 97 16.6k 1.1× 9.5k 1.6× 6.3k 1.1× 3.4k 0.9× 1.0k 0.5× 369 31.4k

Countries citing papers authored by Edgar G. Engleman

Since Specialization
Citations

This map shows the geographic impact of Edgar G. Engleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar G. Engleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar G. Engleman more than expected).

Fields of papers citing papers by Edgar G. Engleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgar G. Engleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar G. Engleman. The network helps show where Edgar G. Engleman may publish in the future.

Co-authorship network of co-authors of Edgar G. Engleman

This figure shows the co-authorship network connecting the top 25 collaborators of Edgar G. Engleman. A scholar is included among the top collaborators of Edgar G. Engleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgar G. Engleman. Edgar G. Engleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, John, Andrew Tucker, Yijiang Chen, et al.. (2026). When Central Tolerance Fails: Thymic Malignancies at the Intersection of Cancer Immunity and Autoimmunity. Cancers. 18(5). 747–747. 1 indexed citations
2.
Chiu, David Kung‐Chun, Xiangyue Zhang, Qiang Liu, et al.. (2025). Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity. Science. 388(6745). eadr3026–eadr3026. 7 indexed citations
3.
Diehl, Markus, Nathan E. Reticker-Flynn, & Edgar G. Engleman. (2025). Harnessing neutrophils to prevent metastasis 3826. The Journal of Immunology. 214(Supplement_1).
4.
Reticker-Flynn, Nathan E. & Edgar G. Engleman. (2023). Lymph nodes: at the intersection of cancer treatment and progression. Trends in Cell Biology. 33(12). 1021–1034. 19 indexed citations
5.
Nambiar, Dhanya K., Vignesh Viswanathan, Hongbin Cao, et al.. (2023). Galectin-1 Mediates Chronic STING Activation in Tumors to Promote Metastasis through MDSC Recruitment. Cancer Research. 83(19). 3205–3219. 26 indexed citations
6.
Reticker-Flynn, Nathan E. & Edgar G. Engleman. (2020). Cancer systems immunology. eLife. 9. 13 indexed citations
7.
Busque, Stéphan, John D. Scandling, Robert Lowsky, et al.. (2020). Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal. Science Translational Medicine. 12(528). 41 indexed citations
8.
Kramer, Jessica R., et al.. (2018). N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2. Angewandte Chemie International Edition. 57(12). 3137–3142. 53 indexed citations
9.
Scandling, John D., Stéphan Busque, Robert Lowsky, et al.. (2018). Macrochimerism and clinical transplant tolerance. Human Immunology. 79(5). 266–271. 24 indexed citations
10.
Abbruzzese, James L., Dana K. Andersen, Carl Borrebaeck, et al.. (2018). The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities. Pancreas. 47(5). 516–525. 44 indexed citations
11.
Kenkel, Justin A., William W. Tseng, Matthew G. Davidson, et al.. (2017). An Immunosuppressive Dendritic Cell Subset Accumulates at Secondary Sites and Promotes Metastasis in Pancreatic Cancer. Cancer Research. 77(15). 4158–4170. 96 indexed citations
12.
Lee, Hyun‐Sung, Gerald J. Berry, Thomas M. Wheeler, et al.. (2016). Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages. Clinical Cancer Research. 23(3). 778–788. 38 indexed citations
13.
Penny, Hweixian Leong, Tyler R. Prestwood, Nupur Bhattacharya, et al.. (2016). Restoring Retinoic Acid Attenuates Intestinal Inflammation and Tumorigenesis in APCMin/+ Mice. Cancer Immunology Research. 4(11). 917–926. 35 indexed citations
14.
Filatenkov, Alexander, Jeanette Baker, Antonia M.S. Mueller, et al.. (2015). Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions. Clinical Cancer Research. 21(16). 3727–3739. 358 indexed citations
15.
Björck, Pia, et al.. (2010). Plasmacytoid Dendritic Cell Dichotomy: Identification of IFN-α Producing Cells as a Phenotypically and Functionally Distinct Subset. The Journal of Immunology. 186(3). 1477–1485. 59 indexed citations
16.
Söderström, Kalle, Emily Stein, Paula Colmenero, et al.. (2009). Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proceedings of the National Academy of Sciences. 107(29). 13028–13033. 144 indexed citations
17.
Engleman, Edgar G., Zachary A. Rodd, Richard L. Bell, & James M. Murphy. (2008). The Role of 5-HT3 Receptors in Drug Abuse and as a Target for Pharmacotherapy. CNS & Neurological Disorders - Drug Targets. 7(5). 454–467. 60 indexed citations
18.
Fong, Lawrence, Dirk G. Brockstedt, Claudia Benike, et al.. (2001). Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy. The Journal of Immunology. 167(12). 7150–7156. 202 indexed citations
19.
Fong, Lawrence, Dirk G. Brockstedt, Claudia Benike, Lijun Wu, & Edgar G. Engleman. (2001). Dendritic Cells Injected Via Different Routes Induce Immunity in Cancer Patients. The Journal of Immunology. 166(6). 4254–4259. 270 indexed citations
20.
Yang, Yue-tao, F. Carl Grumet, B M Fendly, Edgar G. Engleman, & John E. Shively. (1982). Protein A Binding Assay for the Identification of HLA Antigens on Peripheral Blood Lymphocytes by Monoclonal Antibodies: Application to HLA B27. Hybridoma. 1(3). 243–255. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Herbert C. Morse Breakdown of academic impact, for papers by Craig Gérard Breakdown of academic impact, for papers by Vincenzo Cerundolo Breakdown of academic impact, for papers by René A. W. van Lier Breakdown of academic impact, for papers by Thomas J. Schall Breakdown of academic impact, for papers by Dennis A. Carson Breakdown of academic impact, for papers by Ian Clark‐Lewis Breakdown of academic impact, for papers by Barrett J. Rollins Breakdown of academic impact, for papers by Hans Wigzell Breakdown of academic impact, for papers by Howard A. Young
Rankless by CCL
2026